RxDoctor Payments Data

Young Paik, MD

Otolaryngology · Evansville, INNPI 1699973529

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 44.7% of the total.

$3,448in general payments, 2019–2025

Across 136 payments — averaging $25.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$2K
  • Sanofi$803
  • Stryker$242
  • Intersect ENT, Inc.$153
  • Optinose US, Inc.$150
  • Acclarent, Inc$73
  • plus $486 from 16 others

What the payments were for

  • Food & beverage$3,36598%
  • Education$832%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,448 in reported general payments places this provider in the 75th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$287,691
Medicare patients
616
Services billed
4,907

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$41,326
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth44$5,172
Ipratropium Bromide87$2,867
Prednisolone Acetate20$568
Fluticasone Propionate51$505
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$416
Cephalexin74$349
Omeprazole28$313
Ciprofloxacin Hcl23$279
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$209
Methylprednisolone23$138
Prednisone15$114

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →